Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

The COREG And Lisinopril Combination Therapy In Hypertensive Subjects (COSMOS) Trial

ClinicalTrials.gov ID: NCT00347360

Public ClinicalTrials.gov record NCT00347360. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 4:43 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Double-Dummy, Parallel Group, Factorial Design Trial to Assess the Efficacy and Safety of up to Six Weeks Treatment With 20mg, 40mg, or 80mg QD Doses of Carvedilol Controlled Release Formulation (COREG CR) or 10mg, 20mg, or 40mg QD Doses of Lisinopril (Zestril) or a Combination of One of the Doses of Each Medication

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a randomized, double-blind, double-dummy, parallel group trial employing 15 cells of a 4x4 factorial design (no placebo)to compare the hypertensive effects in patients with Stage 1 and Stage 2 hypertension of carvedilol (20, 40 or 80 mg daily) alone, lisinopril (10, 20 or 40 mg daily) alone, and all combinations of the doses.

Study identification

NCT ID
NCT00347360
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
GlaxoSmithKline
Industry
Enrollment
654 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 2006 (Type not available)
Primary completion
Apr 2008 (Actual)
Completion
Apr 2008 (Actual)
Last update posted
Dec 26, 2016

2006 – 2008

United States locations

U.S. sites
151
U.S. states
36
U.S. cities
134
Facility City State ZIP Site status
GSK Investigational Site Anniston Alabama 36207 —
GSK Investigational Site Birmingham Alabama 35215 —
GSK Investigational Site Birmingham Alabama 35216 —
GSK Investigational Site Birmingham Alabama 35235 —
GSK Investigational Site Birmingham Alabama 35242 —
GSK Investigational Site Haleyville Alabama 35565 —
GSK Investigational Site Mobile Alabama 36617 —
GSK Investigational Site Muscle Shoals Alabama 35662 —
GSK Investigational Site Chandler Arizona 85225 —
GSK Investigational Site Gilbert Arizona 85296 —
GSK Investigational Site Glendale Arizona 85308 —
GSK Investigational Site Mesa Arizona 85206 —
GSK Investigational Site Phoenix Arizona 85023 —
GSK Investigational Site Phoenix Arizona 85032 —
GSK Investigational Site Phoenix, Arizona Arizona 86106 —
GSK Investigational Site Scottsdale Arizona 85251 —
GSK Investigational Site Scottsdale Arizona 85260 —
GSK Investigational Site Sun City Arizona 85351 —
GSK Investigational Site Tucson Arizona 85712 —
GSK Investigational Site Tucson Arizona 85741 —
GSK Investigational Site Little Rock Arkansas 72204 —
GSK Investigational Site Searcy Arkansas 72143 —
GSK Investigational Site Beuna Park California 90620 —
GSK Investigational Site Beverly Hills California 90211 —
GSK Investigational Site Burbank California 91505 —
GSK Investigational Site Carlsbad California 92008 —
GSK Investigational Site Fountain Valley California 92708 —
GSK Investigational Site Fresno California 93703 —
GSK Investigational Site Loma Linda California 92354 —
GSK Investigational Site Mission Viejo California 92691 —
GSK Investigational Site Pico Rivera California 90660 —
GSK Investigational Site Rancho Cordova California 95670 —
GSK Investigational Site San Diego California 92117 —
GSK Investigational Site San Diego California 92128 —
GSK Investigational Site Santa Ana California 92705 —
GSK Investigational Site Vista California 92084 —
GSK Investigational Site Walnut Creek California 94598 —
GSK Investigational Site Colorado Springs Colorado 80904 —
GSK Investigational Site Denver Colorado 80206 —
GSK Investigational Site Wilmington Delaware 19805 —
GSK Investigational Site Washington D.C. District of Columbia 20017 —
GSK Investigational Site Coral Gables Florida 33134 —
GSK Investigational Site Hialeah Florida 33013 —
GSK Investigational Site Hollywood Florida 33023 —
GSK Investigational Site Jacksonville Florida 32205 —
GSK Investigational Site Jacksonville Beach Florida 32250 —
GSK Investigational Site Miami Florida 33156 —
GSK Investigational Site Miami Florida 33169 —
GSK Investigational Site Palm Harbor Florida 34684 —
GSK Investigational Site Pembroke Pines Florida 33024 —
GSK Investigational Site Pembroke Pines Florida 33027 —
GSK Investigational Site Sarasota Florida 34239 —
GSK Investigational Site West Palm Beach Florida 33409 —
GSK Investigational Site Gainesville Georgia 30501 —
GSK Investigational Site Marietta Georgia 30066 —
GSK Investigational Site Sandersville Georgia 31082 —
GSK Investigational Site Savannah Georgia 31406 —
GSK Investigational Site Aurora Illinois 60504 —
GSK Investigational Site Chicago Illinois 60607 —
GSK Investigational Site Chicago Illinois 60610 —
GSK Investigational Site Melrose Park Illinois 60160 —
GSK Investigational Site Avon Indiana 46123 —
GSK Investigational Site Bloomington Indiana 47102 —
GSK Investigational Site Fort Wayne Indiana 46804 —
GSK Investigational Site Indianapolis Indiana 46250 —
GSK Investigational Site Ames Iowa 50010 —
GSK Investigational Site Wichita Kansas 67205 —
GSK Investigational Site Slidell Louisiana 70458 —
GSK Investigational Site Springfield Massachusetts 01103 —
GSK Investigational Site Taunton Massachusetts 02780. —
GSK Investigational Site Bingham Farms Michigan 48025 —
GSK Investigational Site Brooklyn Center Minnesota 55430 —
GSK Investigational Site Missoula Montana 59808 —
GSK Investigational Site O Fallon Montana 63366 —
GSK Investigational Site Omaha Nebraska 68131 —
GSK Investigational Site Las Vegas Nevada 89016 —
GSK Investigational Site Las Vegas Nevada 89119 —
GSK Investigational Site Las Vegas Nevada 89128 —
GSK Investigational Site Cherry Hill New Jersey 08034 —
GSK Investigational Site Edison New Jersey 08817 —
GSK Investigational Site Ridgewood New Jersey 7450 —
GSK Investigational Site Voorhees Township New Jersey 08043 —
GSK Investigational Site Albuquerque New Mexico 87102 —
GSK Investigational Site Brooklyn New York 11203 —
GSK Investigational Site Buffalo New York 14215 —
GSK Investigational Site Kingston New York 12401 —
GSK Investigational Site Lewinston New York 14092 —
GSK Investigational Site Tonawanda New York 14150-1810 —
GSK Investigational Site Asheville North Carolina 28801 —
GSK Investigational Site Charlotte North Carolina 28211 —
GSK Investigational Site High Point North Carolina 27262 —
GSK Investigational Site Raleigh North Carolina 27615 —
GSK Investigational Site Fargo North Dakota 58103 —
GSK Investigational Site Cincinnati Ohio 45219 —
GSK Investigational Site Cincinnati Ohio 45236 —
GSK Investigational Site Cleveland Ohio 44106 —
GSK Investigational Site Cleveland Ohio 44195 —
GSK Investigational Site Dayton Ohio 45406 —
GSK Investigational Site Oklahoma City Oklahoma 73103 —
GSK Investigational Site Oklahoma City Oklahoma 73112 —
GSK Investigational Site Tulsa Oklahoma 74104 —
GSK Investigational Site Eugene Oregon 97401 —
GSK Investigational Site Beaver Pennsylvania 15009 —
GSK Investigational Site Doylestown Pennsylvania 18901 —
GSK Investigational Site Erie Pennsylvania 16504 —
GSK Investigational Site Havertown Pennsylvania 19083 —
GSK Investigational Site Landsdale Pennsylvania 19446 —
GSK Investigational Site Leetsdale Pennsylvania 15056 —
GSK Investigational Site Philadelphia Pennsylvania 19152 —
GSK Investigational Site Philadelphia Pennsylvania 19154 —
GSK Investigational Site Warminster Pennsylvania 18974 —
GSK Investigational Site West Chester Pennsylvania 19380 —
GSK Investigational Site Beaufort South Carolina 29906 —
GSK Investigational Site Charleston South Carolina 29403 —
GSK Investigational Site Columbia South Carolina 29201 —
GSK Investigational Site Gaffney South Carolina 29340 —
GSK Investigational Site Greer South Carolina 29651 —
GSK Investigational Site Hilton Head Island South Carolina 29926 —
GSK Investigational Site Manning South Carolina 29102 —
GSK Investigational Site Simpsonville South Carolina 29681 —
GSK Investigational Site Spartanburg South Carolina 29303 —
GSK Investigational Site Sumter South Carolina 29150 —
GSK Investigational Site Taylors South Carolina 29687 —
GSK Investigational Site Union South Carolina 29309 —
GSK Investigational Site Clarksville Tennessee 37043 —
GSK Investigational Site Jackson Tennessee 38305 —
GSK Investigational Site Johnson City Tennessee 37601 —
GSK Investigational Site Nashville Tennessee 37203 —
GSK Investigational Site Selmer Tennessee 38375 —
GSK Investigational Site Arlington Texas 76014 —
GSK Investigational Site Austin Texas 78705 —
GSK Investigational Site Georgetown Texas 78626 —
GSK Investigational Site Grand Prairie/Texas Texas 5052 —
GSK Investigational Site Houston Texas 77081 —
GSK Investigational Site Longview Texas 75605 —
GSK Investigational Site San Antonio Texas 78224 —
GSK Investigational Site San Antonio Texas 78229 —
GSK Investigational Site Sugar Land Texas 77479 —
GSK Investigational Site Temple Texas 76502 —
GSK Investigational Site Waco Texas 76712 —
GSK Investigational Site Murray Utah 84107 —
GSK Investigational Site Salt Lake City Utah 84102 —
GSK Investigational Site Sandy City Utah 84094 —
GSK Investigational Site Arlington Virginia 22205 —
GSK Investigational Site Burke Virginia 22015 —
GSK Investigational Site Chester Virginia 23836 —
GSK Investigational Site Fairfax Virginia 22030 —
GSK Investigational Site Manassas Virginia 20110 —
GSK Investigational Site Spokane Washington 99206 —
GSK Investigational Site Tacoma Washington 98405 —
GSK Investigational Site Milwaukee Wisconsin 53209 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00347360, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 26, 2016 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00347360 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →